Argenx
ARGX
#404
Rank
โ‚ฌ53.59 B
Marketcap
861,88ย โ‚ฌ
Share price
-0.55%
Change (1 day)
37.30%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚ฌ41.04 Million

According to Argenx 's latest financial reports the company's total debt is โ‚ฌ41.04 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2019 to 2020)

Total debt by year

Year Total debt Change
2013-12-31N/A-100%
2012-12-31โ‚ฌ2.23 M2.04%
2011-12-31โ‚ฌ2.19 M